ConductScience.org, home

Paper39195022

Biohybrids for Combined Therapies of Skin Wounds: Agglomerates of Mesenchymal Stem Cells with Gelatin Hydrogel Beads Delivering Phages and Basic Fibroblast Growth Factor.

Moghtader F and 2 others. Gels, 2024. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Biohybrids for Combined Therapies of Skin Wounds: Agglomerates of Mesenchymal Stem Cells with Gelatin Hydrogel Beads Delivering Phages and Basic Fibroblast Growth Factor. Papers, record 39195022. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39195022

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Biohybrids for Combined Therapies of Skin Wounds: Agglomerates of Mesenchymal Stem Cells with Gelatin Hydrogel Beads Delivering Phages and Basic Fibroblast Growth Factor.
PubMed
Journal
Gels
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
2
iCite
Relative citation ratio, by iCite
0.53, provisional
iCite
Revised in PubMed
2024-08-30
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Moghtader FFarzanehhttps://orcid.org/0009-0003-5988-6280
2Tabata YYasuhiko
3Karaöz EErdal

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References42

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133474609Phage therapy as strategy to face post-antibiotic era: a guide to beginners and experts.Arch Microbiol2021https://conductscience.org/library/papers/33474609PubMed
233251170Microbial Resistance Movements: An Overview of Global Public Health Threats Posed by Antimicrobial Resistance, and How Best to Counter.Front Public Health2020https://conductscience.org/library/papers/33251170PubMed
335969943The resurgence of phage-based therapy in the era of increasing antibiotic resistance: From research progress to challenges and prospects.Microbiol Res2022https://conductscience.org/library/papers/35969943PubMed
432582107Phage Therapy in the Year 2035.Front Microbiol2020https://conductscience.org/library/papers/32582107PubMed
535745750Progress in Gelatin as Biomaterial for Tissue Engineering.Pharmaceutics2022https://conductscience.org/library/papers/35745750PubMed
637242741Current Trends in Gelatin-Based Drug Delivery Systems.Pharmaceutics2023https://conductscience.org/library/papers/37242741PubMed
731150750Growth factor delivery: Defining the next generation platforms for tissue engineering.J Control Release2019https://conductscience.org/library/papers/31150750PubMed
838667663Alginate- and Chitosan-Modified Gelatin Hydrogel Microbeads for Delivery of E. coli Phages.Gels2024https://conductscience.org/library/papers/38667663PubMed
926649054Spheroid Culture of Mesenchymal Stem Cells.Stem Cells Int2016https://conductscience.org/library/papers/26649054PubMed
1024784429Perspective: The age of the phage.Nature2014https://conductscience.org/library/papers/24784429PubMed
1128749427Advanced Growth Factor Delivery Systems in Wound Management and Skin Regeneration.Molecules2017https://conductscience.org/library/papers/28749427PubMed
1228760079Preparation of cell aggregates incorporating gelatin hydrogel microspheres containing bone morphogenic protein-2 with different degradabilities.J Biomater Sci Polym Ed2018https://conductscience.org/library/papers/28760079PubMed
1336567474Advances in Skin Tissue Engineering and Regenerative Medicine.J Burn Care Res2023https://conductscience.org/library/papers/36567474PubMed
1426464037Antimicrobial resistance: A global emerging threat to public health systems.Crit Rev Food Sci Nutr2017https://conductscience.org/library/papers/26464037PubMed
1528450938Isolation, culture and identification of human adipose-derived stem cells.Exp Ther Med2017https://conductscience.org/library/papers/28450938PubMed
1631185183Phage Therapy in the Twenty-First Century: Facing the Decline of the Antibiotic Era; Is It Finally Time for the Age of the Phage?Annu Rev Microbiol2019https://conductscience.org/library/papers/31185183PubMed
1726793421Fibroblast growth factors as tissue repair and regeneration therapeutics.PeerJ2016https://conductscience.org/library/papers/26793421PubMed
1810358220Biodegradation of hydrogel carrier incorporating fibroblast growth factor.Tissue Eng1999https://conductscience.org/library/papers/10358220PubMed
1917905994Escherichia coli physiology in Luria-Bertani broth.J Bacteriol2007https://conductscience.org/library/papers/17905994PubMed
2032506250The Japanese Experience with Basic Fibroblast Growth Factor in Cutaneous Wound Management and Scar Prevention: A Systematic Review of Clinical and Biological Aspects.Dermatol Ther (Heidelb)2020https://conductscience.org/library/papers/32506250PubMed

See all 42 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
42794367Albumin Hydrogels Loading Bacteriophage PA57 as a Promising Platform for Pseudomonas aeruginosa Infection Management.Gels2026https://conductscience.org/library/papers/42794367PubMed
42267833Bacteriophages in the treatment of cutaneous infections and skin disorders: therapeutic advances and future directions.Clin Microbiol Rev2026https://conductscience.org/library/papers/42267833PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39195022

GET https://conductscience.org/api/papers/v1/39195022/references?page=2